Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
buthionine sulfoximine and glutathione depletion

buthionine sulfoximine and glutathione depletion Disturbing the Redox Balance Using Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE Glutathione depletion induces oxidative injury

Glutathione depletion induces oxidative injury and apoptosis via TRPM2 channel activation in renal collecting duct cells ScienceDirect The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal Hypertoxic self assembled peptide with dual functions of glutathione depletion and biosynthesis inhibition for selective tumor ferroptosis and pyroptosis Journal of Nanobiotechnology Springer Nature Link Oncology Letters

SKU: 34732682380 · From equiscorp.hu

4.2
USD24.18 USD50.18

Pay in 4 interest-free payments of $6.04 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

You swapped chips for hummus

buthionine sulfoximine and glutathione depletion Disturbing the Redox Balance Using Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE Glutathione depletion induces oxidative injury

Phelps NH, Singleton RK, Zhou B, Heap RA, Mishra A, Bennett JE, et al

buthionine sulfoximine and glutathione depletion Disturbing the Redox Balance Using Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE Glutathione depletion induces oxidative injury

SIRT6 promotes angiogenesis and hemorrhage of carotid plaque via regulating HIF-1 and reactive oxygen species

buthionine sulfoximine and glutathione depletion Disturbing the Redox Balance Using Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE Glutathione depletion induces oxidative injury

Gut Health and Digestive Benefits Given its origin in gastric juice, BPC-157 shows particular affinity for gastrointestinal tissue

buthionine sulfoximine and glutathione depletion Disturbing the Redox Balance Using Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE Glutathione depletion induces oxidative injury
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

BPC-157 5mg

US$ 23.96

4.2 (15 reviews)

recommand products